Lauwerys B
Lauwerys B
UCB Biopharma
Потвърден имейл адрес: ucb.com
Transancestral mapping and genetic load in systemic lupus erythematosus
CD Langefeld, HC Ainsworth, DSC Graham, JA Kelly, ME Comeau, ...
Nature communications 8 (1), 16021, 2017
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18
BR Lauwerys, N Garot, JC Renauld, FA Houssiau
The Journal of Immunology 165 (4), 1847-1853, 2000
Synovial tissue research: a state-of-the-art review
C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Cañete, ...
Nature Reviews Rheumatology 13 (8), 463-475, 2017
The anti‐CD20 antibody rituximab reduces the Th17 cell response
FL van de Veerdonk, B Lauwerys, RJ Marijnissen, K Timmermans, ...
Arthritis & Rheumatism 63 (6), 1507-1516, 2011
Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus
AN Toukap, C Galant, I Theate, AL Maudoux, RJU Lories, FA Houssiau, ...
Arthritis & Rheumatism 56 (5), 1579-1588, 2007
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
IEA Hoffman, BR Lauwerys, F De Keyser, TWJ Huizinga, D Isenberg, ...
Annals of the rheumatic diseases 68 (3), 412-415, 2009
Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18
BR Lauwerys, JC Renauld, FA Houssiau
Cytokine 11 (11), 822-830, 1999
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open …
F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ...
The Lancet 397 (10271), 305-317, 2021
Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid
BR Lauwerys, E Hachulla, F Spertini, E Lazaro, C Jorgensen, X Mariette, ...
Arthritis & Rheumatism 65 (2), 447-456, 2013
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
F Tamirou, BR Lauwerys, M Dall'Era, M Mackay, B Rovin, R Cervera, ...
Lupus science & medicine 2 (1), e000123, 2015
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene
SE Löfgren, J Frostegård, L Truedsson, BA Pons-Estel, S D'Alfonso, ...
Genes & Immunity 13 (3), 268-274, 2012
Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab …
P Durez, J Malghem, AN Toukap, G Depresseux, BR Lauwerys, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
BR Lauwerys, J Ducreux, FA Houssiau
Rheumatology 53 (8), 1369-1376, 2014
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
P Raj, E Rai, R Song, S Khan, BE Wakeland, K Viswanathan, C Arana, ...
elife 5, e12089, 2016
Side-effects of intravenous cyclophosphamide pulse therapy
F Martin, B Lauwerys, C Lefebvre, JP Devogelaer, FA Houssiau
Lupus 6 (3), 254-257, 1997
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
V Badot, C Galant, A Nzeusseu Toukap, I Theate, AL Maudoux, ...
Arthritis research & therapy 11, 1-13, 2009
Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature
JCH van der Hilst, M Moutschen, PE Messiaen, BR Lauwerys, ...
Biologics: Targets and Therapy, 75-80, 2016
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
HI Brunner, N Ruperto, N Tzaribachev, G Horneff, VG Chasnyk, ...
Annals of the rheumatic diseases 77 (1), 21-29, 2018
Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab
AA Grom, NT Ilowite, V Pascual, HI Brunner, A Martini, D Lovell, ...
Arthritis & Rheumatology 68 (1), 218-228, 2016
Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis
JF Classen, D Henrohn, F Rorsman, J Lennartsson, BR Lauwerys, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20